SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (220)5/15/2002 11:11:53 AM
From: Biomaven  Read Replies (1) | Respond to of 897
 
before real world short

Alas in the real world, shorting BB stocks is extremely difficult, if not impossible, for most investors. This is not a legal obstacle (short sales of BB stocks are unregulated by the SEC) but rather a practical one - most brokers just won't let you do it.

Anyone with a US brokerage account been successful at shorting a BB stock?

Peter



To: scaram(o)uche who wrote (220)10/3/2002 6:03:54 PM
From: tuck  Read Replies (1) | Respond to of 897
 
Since this is an SI portfolio, I'm going for it now.

Message 18070121

The portfolio will short a full position of GMXX at the closing price of $8.15. Will add if needed; this should be a good till zero.

Also keeping an eye on AMGN, which is having a good recovery. Still think it's overvalued; that the Immunex merger will be tough.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News